首页> 外文期刊>Frontiers in Medicine >Distribution and Antibiotic Resistance Patterns of Pathogenic Bacteria in Patients With Chronic Cutaneous Wounds in China
【24h】

Distribution and Antibiotic Resistance Patterns of Pathogenic Bacteria in Patients With Chronic Cutaneous Wounds in China

机译:中国慢性皮肤伤患者致病菌的分布和抗生素抗性模式

获取原文
           

摘要

Background: To determine the distribution and antimicrobial susceptibility pattern of pathogenic bacteria in patients with chronic cutaneous wounds on a national scale. Methods: A retrospective study was conducted using the data recorded between January 1, 2018 and January1, 2020 in 195 hospitals across China. After screening the data, 815 patients with chronic wounds were finally analyzed. The data collected included information about the patients' general condition and local cutaneous wound assessments, especially microbial culture and antibiotic susceptibility tests. The analyses were performed using SPSS Version 26. Results: The study included 815 patients (290 [35.6%] females; 63 [50–74] years). The most common causes of chronic cutaneous wounds were diabetes (183, 22.5%), infection (178, 21.8%), and pressure (140, 17.2%). Among these, 521(63.9%) samples tested yielded microbial growth, including 70 (13.4%) polymicrobial infection and 451 (86.6%) monomicrobial infection. The positive rate of microbial culture was highest in wound tissue of ulcers caused by infection (87.6%), followed by pressure (77.1%), diabetes (68.3%), and venous diseases (67.7%). Bates-Jensen wound assessment tool (BWAT) scores 25 and wounds that lasted for more than 3 months had a higher positive rate of microbial culture. BWAT scores 25 and wounds in the rump, perineum, and feet were more likely to exhibit polymicrobial infection. A total of 600 strains were isolated, of which 46.2% (277 strains) were Gram-positive bacteria, 51.3% (308 strains) were Gram-negative bacteria, and 2.5% (15 strains) were fungi. The most common bacterial isolates were Staphylococcus aureus (29.2%), Escherichia coli (11.5%), Pseudomonas aeruginosa (11.0%), Proteus mirabilis (8.0%), and Klebsiella pneumoniae (5.8%). The susceptibility tests showed that 116 cultured bacteria were Multidrug resistant (MDR) strains. The resistance rates of S. aureus were 92.0% (161/175) to penicillin, 58.3% (102/175) to erythromycin, and 50.9% (89/175) to clindamycin. Vancomycin was the most effective antibiotic (0% resistance rate) against all Gram-positive bacteria. Besides, the resistance rates of E. coli were 68.1% (47/69) to ampicillin, 68.1% (47/69) to ciprofloxacin, 60.9% (42/69) to levofloxacin. However, all the isolated Gram-negative bacteria showed low resistance rates to tigecycline (3.9%) and amikacin (3.6%). Conclusions: The distribution of bacteria isolated from chronic cutaneous wounds varies with the BWAT scores, causes, duration, and the location of wounds. Multidrug resistance is a serious health issue, and therefore antibiotics used in chronic wounds must be under strict regulation. Our findings may help clinicians in making informed decisions regarding antibiotic therapy.
机译:背景:确定全国慢性皮肤伤口患者致病菌的分布和抗菌敏感模式。方法:采用2018年1月1日至1月1日至195日在中国的医院录制的数据进行了回顾性研究。筛选数据后,最终分析了815名慢性伤口患者。收集的数据包括有关患者的一般情况和本地皮肤伤口评估的信息,特别是微生物培养和抗生素易感性测试。使用SPSS版本26进行分析。结果:该研究包括815名患者(290 [35.6%]女性; 63 [50-74]年)。慢性皮肤伤口最常见的原因是糖尿病(183,22.5%),感染(178,21.8%)和压力(140,17.2%)。其中,521(63.9%)试验的样品产生微生物生长,包括70(13.4%)多发性感染和451(86.6%)单体性感染。微生物培养的阳性培养率在感染引起的溃疡伤口组织中最高(87.6%),其次是压力(77.1%),糖尿病(68.3%)和静脉疾病(67.7%)。 Bates-Jensen伤口评估工具(BWAT)分数& 25和持续超过3个月的伤口具有更高的微生物培养速率。 BWAT得分& 25和臀部,颚和脚的伤口更有可能表现出多元化感染。分离了总共600个菌株,其中46.2%(277株)是革兰氏阳性细菌,51.3%(308株)是革兰氏阴性细菌,2.5%(15%)是真菌。最常见的细菌分离物是金黄色葡萄球菌(29.2%),大肠杆菌(11.5%),假单胞菌铜绿假单胞菌(11.0%),Proteus mirabilis(8.0%)和Klebsiella Pneumonee(5.8%)。易感性测试表明,116种培养的细菌是多药抗性(MDR)菌株。对青霉素的抗性抗性率为92.0%(161/175),对红霉素58.3%(102/175),50.9%(89/175)至Clindamycin。万古霉素是对所有革兰氏阳性细菌最有效的抗生素(抗性率)。此外,大肠杆菌的耐药率为68.1%(47/69)至氨苄青霉素,68.1%(47/69)至环丙沙星,60.9%(42/69)至左氧氟沙星。然而,所有孤立的革兰氏阴性细菌表现出降低素(3.9%)和Amikacin(3.6%)的低阻力率。结论:慢性皮肤伤口分离的细菌的分布随着BWAT分数,原因,持续时间和伤口位置而变化。多药抗性是一个严重的健康问题,因此慢性伤口中使用的抗生素必须受到严格的监管。我们的研究结果可能有助于临床医生在抗生素治疗方面做出明智的决定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号